Foresite Capital

Foresite Capital is a multi-stage investment firm focused on healthcare and life sciences, funding companies across different stages of their life cycle in areas of unmet medical need. It describes its approach as data science-driven, aiming to combine technology and biotech expertise to identify shifts in the sector before they become widely apparent. Its portfolio has included Eikon Therapeutics, a clinical-stage biopharmaceutical company that the firm says it supported from an early concept through its later growth. Testimonials on its site reference the firm's involvement in projects addressing cancer treatment resistance and the combination of healthcare data in a privacy-compliant way.